Capital and sustainability by Wyse, Roger
I will provide an investor’s perspective on the dramatic changes occurring in agriculture. 
at Burrill & Company, we invest across the life sciences—in therapeutics and drugs, 
industrial biotechnology, agriculture, and health and wellness. from my perspective, 
much of the innovation coming from universities and going into early-stage companies 
is where the innovation will occur to enable the area of industrial biotechnology as a 
whole, of which biofuels is one part. at Burrill we have ~$850 million and we have a 
banking group that’s assisting companies in doing deals across the life sciences—a mer-
chant banking operation. In terms of current funds, we are investing about half of our 
portfolio, ~$400 million, which we expect to increase to ~$ billion in the near future. 
It’s a significant amount of capital to be investing. I will provide the perspective of our 
obligations to our investors as we look now at opportunities to invest in the emerging 
area of industrial biotechnology.
Sustainable area for Investment
The most important question is, “will this be a sustainable area for investment?” It’s 
gotten frothy very quickly. So, as we go forward, where will the money come from? 
where will the certainty needed to make investments come from? what is the regulatory 
environment going to look like? Investors abhor uncertainty. There is a misperception 
that venture capitalists invest in high-risk companies. we don’t. we try to avoid all the 
risk possible. one of the unknowns in this area is the regulatory/policy environment and 
if that uncertainty persists, money that has been flowing into this industry will begin to 
flow elsewhere.
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tipping Point
In 005, industrial biotechnology hit a tipping point and the ride since has been interest-
ing. obviously it caught attention, all the way up to President Bush, who commented on 
it in his 005 state-of-the-union address. In California, Governor Schwarzenegger has 
taken the lead in making significant investments to reduce emission of greenhouse gases. 
These developments are all about energy security and politics, in particular rural politics. 
The price of oil rose dramatically whereas the price of corn stayed the same, ~$/bushel, 
as it has been for many years. That discrepancy provided the incentive for rural politics to 
engage, to begin looking at options for increasing the value of the commodity crops that 
we produce. The other factor was global security of the oil supply; many of the countries 
from which the United States purchases oil are in political turmoil. Then Katrina struck 
and revealed additional insecurities in US refining capacity. all of this happened at about 
the same time and then suddenly “green” became politically correct.
I have been concerned for some time that industrial biotechnology is long on tech-
nology and short on markets. a good example in the Midwest is the Dow-Cargill joint 
venture, natureworks LLC, with almost a billion dollars spent in developing the tech-
nology and the plant in Blair, ne. That plant had economic problems until wal-Mart 
said, “we’re going green. we’re going to use your product for disposable packaging for 
the future.” Suddenly that plant looks like a much more economically viable investment. 
This example demonstrates that you can have all the technology in the world but market 
timing is important.
So, around 005 there was a perfect storm. we had enabling technologies in the United 
States in various energy bills and the ag bill, and in the european Union, policies were 
put in place favoring biodiesel, for example. Much technology had been developed and 
we’d sequenced a lot of organisms. we understood how to convert plant-made feedstocks 
into valuable commodities and market-pull came in, enabling things to happen fast. Some 
would argue that things happened almost too fast. There was a rapid increase in the number 
of ethanol plants, as was expected. a significant fraction of the US corn crop is going into 
ethanol production, corn prices have risen dramatically and we are now in a debate about 
feed vs. fuel. additionally, investors saw this as an opportunity. The “cleantech” guys had 
been looking at alternative-energy investments for a number of years and suddenly there 
was a dramatic shift of equity capital into this space.
rural revitalization
rural america is uniquely energized. I met with a farm-credit group recently, considering 
putting money into venture capital to invest in rural america—the revitalization occurring 
in the Midwest is amazing. I gave a talk in wall Street a while back and made the argument 
that ethanol was getting too frothy, that they should invest in John Deere, considering 
what farmers do when they make a lot of money—they buy a new tractor or pick-up 
truck and they remodel their wife’s kitchen. The implications for us have been dramatic 
both in rural development as well as in terms of companies developing technologies and 
bringing new products to market.
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an important point is that this is not just about energy. we are looking at dramatic 
growth in the area of industrial applications of biotechnology. The Mackenzie reports have 
talked about a $500 billion increase in the chemical industry, half coming from inputs 
from biotechnology. So, a lot will happen outside the area of biofuels and we have the 
technologies in hand to make those changes. There will still be improvements, but we 
can now move into those areas as well. It’s all about the economics.
another important aspect is that when we invest in a company, we work hard to grow 
its value. However, until we can exit that company, until we can sell it to some larger 
company or until we can take it public, it’s not a good investment for us. Public markets 
have gotten very interested in alternative energy and sustainability. Metabolix was a small 
company that developed a technology for production of plastics in plants and via fermen-
tation; after a deal with aDM, they announced that they had a name for their product 
and their stock price went up dramatically. The markets are beginning to look at this area 
as important space and they are looking also at John Deere, Monsanto, etc.—the people 
who are investing in it—and their stock prices are growing nicely as well. 
Investment Cooling off
However, the biofuels area got a lot of frothy investment that tapered off dramatically. a 
lot of the ethanol plays that went into the public marketplace saw much activity, but then 
cooled off because of uncertainty in policy and in the price of corn. If I look at investing in 
an ethanol plant and see corn at around $4, that’s not a good investment. twelve percent 
on your money is not a venture investment. we are seeing the economic reality of these 
investments setting in, which will shake out over the next couple of years.
vC Investment in Innovative Companies
another important aspect is that a large number of small innovative companies have 
developed. Those that have technology—or are aggregating technologies—will enable 
this industry into the future. a few of those small companies are listed in table . for 
example, LS9 is Chris Somerville’s in conjunction with Jay Keasling. They are putting genes 
from plants into microorganisms, enabling new pathways for exploitation in fermentors. 
Khosla ventures—in the newspapers almost every day—is one of the funding sources. 
another biotech company is amyris, a spin-out from Berkeley, that has put the isoprenoid 
pathway into E. coli, achieving high levels of production for use as an anti-malaria drug. 
This is another Khosla investment. Muscoma, a company converting cellulose for ethanol 
production, recently raised $30 million.
today’s innovations, which will be tomorrow’s enabling technologies, are attracting 
venture-capital investments to such an extent that we are almost back to the “dot-com” 
era. Some technologies coming to us are still in the laboratory stage. recently we saw a 
conversion technology for glycerol, with proof-of-concept in an erlenmeyer flask and 
they were talking about pre-money valuations of somewhere around $8 million, whereas 
it’s probably a $500,000 value at that state. So, things are getting frothy again, and 
people like us are going deep into universities to find technologies that can be put into 
companies. at Burrill we are very cautious about the kinds of things we are looking for 
and looking at.
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to provide perspective, $5 billion were invested in 006 across all ventures, including 
the life sciences, It and high tech. about $5 billion of that went into biotechnology. In 
fig.  I haven’t dissected out of the cleantech sector, what was bio and what was solar, 
fuel cells, wind, etc., but there has been dramatic growth in cleantech, exceeding $.9 
billion in 006. we are on track for around $4.5 billion in 007—a tremendous move-
ment of capital into this space. revenues from the biotech industry approached $00 
billion in mid-007. The amount coming out of industrial biotech is in the $0–30 
billion range. Clearly, in a couple of years, revenues from industrial biotechnology will 
exceed those from traditional biotech, which have been related chiefly to drug develop-
ment and healthcare.
Table 1. new Companies Formed and Funded by venTure CapiTal.
Company Location VC source Funding to date
   ($ million)
LS9 San Carlos, Ca flagship ventures
  Khosla ventures 5
amyris Biotechnologies emeryville, Ca Khosla ventures
  KPCB, tPG 0
Mascoma, Inc. Cambridge, Ma atlas, flagship
  General Catalyst
  KPCB, Pinnacle
  vPvP, Khosla 30
Seattle Biodiesel Seattle, wa nth Power
  technology ventures
  vault Capital
  vulcan Capital 7.5
aurora Biofuels alameda, Ca noventi
  oak Investment 3.
Greenergy London, UK Cargill (5% equity)
e3 Biofuels Mead, nB Unknown
Mission Biofuels Malaysia Unknown
Southern Biofuels Jackson, MS n/a 0
earth Biofuels Dallas, tX apollo, Cornell
  Downsview, evolution
  Heights, Polygon
  Kamunting, ramius
  rG Capital, Sandell 5.5
United Biofuels York, Pa agrifuel
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Challenges
The real question for us on a daily basis as we look at investment opportunities is: is this 
all sustainable from an investment standpoint? I think that food vs. fuel will continue to 
be an issue—it’s getting prominent play today. Is all this change too disruptive? when I 
talk to farmers, they say they are making money off the ethanol plant they invested in, 
but they are losing on the livestock side because of high costs of feed. Don’t discount 
challenges we have had with monoculture of corn in the Midwest. If we grow wall-to-wall 
corn, also using stover to make cellulosic ethanol, we may be heading for an ecological 
disaster. I still think corn is the right source of feedstocks for the industrial area but it 
may not be corn grown in the Midwest.
at a broader conference we’d be talking about wind, solar, fuel cells—even nuclear—as 
other options for investment. The bio-area has gotten very frothy for obvious reasons, 
but we have to think about the competition. as prices rise, investment money is going to 
move elsewhere, where it’s already getting attention. However, a lot of people, including 
myself, think it will be sustainable. I think we’ve seen a real change in how we are going 
to approach sustainability. Bill Joy, one of the founders of Sun Microsystems with vinod 
Khosla—a very aggressive investor in this space—stated recently at a cleantech forum 
in Germany: “a global response to climate change will spur a business revolution bigger 
than the internet.” This effect will be particularly dramatic in the chemicals industry and 
much greater than it has been in the area of healthcare. 
figure . venture investments in cleantech are growing rapidly;
total venture investments in 006: $5 billion, biotech vC: $5 billion.
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In Summary
Biotechnology—the underlying understanding of life processes that can be applied in the 
industrial area—has reached the point where we can be efficient and effective in imple-
menting technologies for solutions in the industrial area. The technology is in place and we 
will continue to improve it, and markets are there now and ready for the products. Things 
are in alignment and there will be a long-term investment play. we’re going through a 
frothy period, but it will settle out in a few years and stabilize with policies in place. we’ll 
understand the markets and it will be a long-term and exciting place to be.
large companies. The firm has over $850 million under management.
Dr. wyse chairs or serves on the boards of eleven private companies. He is co-
chairman of the newly formed $50 million Malaysian Life Capital fund, and 
is a member of the International advisory Panel for Biotechnology (BioIaP) for 
the prime minister of Malaysia. He was founder and chairman of the alliance 
for animal Genome research.
Immediately prior to joining Burrill, wyse served for 5 years as dean of the 
College of agricultural and Life Sciences at the University of wisconsin-Madison, 
and from 986 to 99 he served as dean of research at rutgers University.
His basic studies in plant biochemistry produced more than 50 scientific 
papers. He received the arthur flemming award in 98 as the outstanding 
Young Scientist in the US federal Service, and was elected a fellow of both the 
Crop Science Society of america and the american Society of agronomy. 
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